PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease Reportschickenpox
MeSH D002644 - chickenpox
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D000073618:Varicella zoster virus infection
0 Companies
0 Drugs
Success rate
D002644: 
Chickenpox
$
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
TevaAcyclovir Acyclovir  1997-04-22   
Famciclovir Famciclovir  2007-08-24   
Valacyclovir Valacyclovir  2010-05-24   
PadagisAcyclovir Acyclovir  2019-02-20   
Taro PharmaceuticalAcyclovir Acyclovir  2016-12-21   
Glenmark PharmaceuticalsAcyclovir Acyclovir  2017-07-31   
MylanAcyclovir Acyclovir  1998-04-13   
Valacyclovir Valacyclovir  2010-05-24   
Acyclovir Zovirax  1985-01-25   
NATCO PharmaFamciclovir Famciclovir  2011-03-24   
XiromedAcyclovir Acyclovir  2020-01-29   
GSKValacyclovir Valtrex  1995-06-23   
Acyclovir Zovirax  1982-10-22   
CiplaAcyclovir Acyclovir  2019-01-18   
Famciclovir Famciclovir  2011-03-21   
Valacyclovir Valacyclovir  2010-05-24   
SandozValacyclovir Valacyclovir  2010-05-24   
1
2
3
4
5
6
>
Clinical Trials
Historical Success Rate
Phase 1
100%
1/1
Phase 2
100%
2/2
Phase 3
64%
7/11
Approved: 4Overall Success rate: 64%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Teva
1
2
3
4
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use